Christina Chan
Senior Vice President, Corporate AffairsRegeneron Pharmaceuticals
PharmaceuticalsView Profile →Chief Corporate Affairs Officer · Novartis
Michelle Weese is Novartis’s chief corporate affairs officer. Her career combines pharmaceutical and consumer-business corporate affairs with founding and leading the consultancy strat-igence.
Last reviewed: Nov 15, 2026
Michelle Weese is Novartis’s chief corporate affairs officer. Her career combines pharmaceutical and consumer-business corporate affairs with founding and leading the consultancy strat-igence.
Weese earned a journalism degree at Georgia State University and developed her corporate-affairs career at Mars. Between 1999 and 2009 she held roles of increasing responsibility there, including global head of Communications.
She founded strat-igence in 2009 and served as its CEO. The consultancy worked with biopharmaceutical and consumer packaged-goods businesses on corporate affairs, crisis management and organizational transformation.
From 2019 to 2021 Weese was general secretary for Danone in North America. Her portfolio included legal, regulatory and compliance functions alongside government affairs, communications, community relations, scientific affairs and sustainability.
She joined Bristol Myers Squibb as executive vice president for Corporate Affairs in 2021 before moving to Novartis on July 10, 2023. At Novartis, her function brings together public and government affairs, communications and engagement, and Global Health & Sustainability.
Bachelor’s degree — Georgia State University — Journalism.